AMAG Pharmaceuticals, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced total revenue was USD 93.106 million compared to USD 83.808 million a year ago. Operating income was USD 1.595 million compared to operating loss of USD 18.347 million a year ago. Net income was USD 9.702 million compared to net loss of USD 23.940 million a year ago. Basic earnings per share from continuing operations was USD 0.28 compared to basic loss per share from continuing operations of USD 0.71 a year ago. For the nine months, total revenue was USD 210.637 million compared to USD 237.062 million a year ago. Operating loss was USD 28.422 million compared to USD 252.547 million a year ago. Net loss was USD 31.466 million compared to USD 267.509 million a year ago. Basic loss per share from continuing operations was USD 0.92 compared to USD 7.85 a year ago.